Wake-up haul: an Ozempic moment for the brain

Orexins are peptides involved in the body’s sleep-wake system—and are big pharma’s next big thing. Like multi-purpose GLPs, they may have far more uses than just regulating shuteye. We ask why Japan’s post-war innovation boom petered out, and what must be done to breed more unicorns . And why procrastination seems to be on the rise, and how to beat it . Guests and host: Shailesh Chitnis, global business correspondent Ethan Wu, Asia business and finance editor Benjamin Sutherland, science writer Rosie Blau, co-host of “The Intelligence” Jason Palmer, co-host of “The Intelligence” Topics covered: orexins, peptides, sleep disorders, pharmaceuticals Japan, innovation, startups procrastination Listen to what matters most, from global politics and business to science and technology— subscribe to The Economist . Hosted on Acast. See acast.com/privacy for more information.